Valganciclovir in the prevention of cytomegalovirus following allogeneic stem cell transplantation.

被引：0
|
作者：
Magalhaes-Silverma, Margarida [1 ]
Parrott, Karen [1 ]
Carter, Thomas [1 ]
Leopold, Christina [1 ]
Raymond, Hohl [1 ]
Roger, Gingrich [1 ]
机构：
[1] Univ Iowa, Iowa City, IA USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.2851.2851
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2851
引用
收藏
页码：807A / 807A
页数：1
相关论文
共 50 条
  • [1] Valganciclovir for the early prophylaxis of cytomegalovirus (CMV) infection after allogeneic stem cell transplantation.
    Bachier, C
    Shaughnessy, P
    Wall, D
    Grimley, M
    Carrum, G
    Freytes, C
    Callander, N
    Walsh, T
    LeMaistre, CF
    [J]. BLOOD, 2004, 104 (11) : 352B - 352B
  • [2] Retrospective analysis of the use of valganciclovir in the prevention of cytomegalovirus following stem cell transplantation
    Subedi, J
    Chappell, J
    Ingram, W
    Zuckerman, M
    Devereux, S
    Ho, A
    Mufti, G
    Pagliuca, A
    [J]. BONE MARROW TRANSPLANTATION, 2004, 33 : S209 - S209
  • [3] Cytomegalovirus infections following reduced-intensity allogeneic stem cell transplantation.
    Nakamura, R
    Cohen, S
    Palmer, J
    Hawkins, G
    Tegtmeier, B
    Spielberger, R
    Smith, E
    Ito, J
    O'Donnell, MR
    Smith, D
    Zaia, JA
    Forman, SJ
    [J]. BLOOD, 2004, 104 (11) : 617A - 617A
  • [4] Prevention of cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation with valganciclovir: Single center experience
    Rzepecki, P.
    Barzal, J.
    Sarosiek, T.
    Oborska, S.
    Szczylik, C.
    [J]. JOURNAL OF CHEMOTHERAPY, 2008, 20 (01) : 140 - 142
  • [5] Foscarnet for cytomegalovirus preemptive therapy following autologous and allogeneic hematopoietic stem cell transplantation.
    Stacy, TB
    Connaghan, DG
    Holland, HK
    Morris, LE
    [J]. BLOOD, 2002, 100 (11) : 629A - 629A
  • [6] Treatment of cytomegalovirus infection with oral valganciclovir in allogeneic haematopoietic stem cell transplantation
    Uresandi, A
    Bermudez, A
    Yañez, L
    Gonzalez-Mesones, B
    Puente, M
    Baro, J
    Conde, E
    Iriondo, A
    [J]. BONE MARROW TRANSPLANTATION, 2006, 37 : S187 - S187
  • [7] An update on the management and prevention of cytomegalovirus infection following allogeneic hematopoietic stem cell transplantation
    Perez Romero, Pilar
    Blanco, Pilar
    Gimenez, Estela
    Solano, Carlos
    Navarro, David
    [J]. FUTURE VIROLOGY, 2015, 10 (02) : 113 - 134
  • [8] Readmissions following allogeneic hematopoietic stem cell transplantation.
    Spring, Laura
    Li, Shuli
    Soiffer, Robert
    Alyea, Edwin
    Glotzbecker, Brett
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (31)
  • [9] Valganciclovir for the prophylaxis of early cytomegalovirus (CMV) infection after allogeneic stem cell transplantation
    Bachier, C
    Shaughnessy, P
    Wall, D
    Grimley, M
    Carrum, G
    Freytes, C
    Callander, N
    Walsh, T
    LeMaistre, CF
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 90 - 91
  • [10] Oral valganciclovir as preemptive therapy for cytomegalovirus infection post allogeneic stem cell transplantation
    Busca, A.
    de Fabritiis, P.
    Ghisetti, V.
    Allice, T.
    Mirabile, M.
    Gentile, G.
    Locatelli, F.
    Falda, M.
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2007, 9 (02) : 102 - 107
12345